Mirum Pharmaceuticals, Inc. (MIRM)
96.53
-0.78
(-0.80%)
USD |
NASDAQ |
May 01, 16:00
96.50
-0.03
(-0.03%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Liabilities (Quarterly) : 528.12M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | 3.013B |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Insmed, Inc. | 1.526B |
| Ionis Pharmaceuticals, Inc. | 2.959B |
| Cogent Biosciences, Inc. | 301.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 842.81M |
| Shareholders Equity (Quarterly) | 314.69M |
| Debt to Equity Ratio | 1.015 |
| Current Ratio | 2.671 |
| Net Debt Paydown Yield | -0.01% |